» Articles » PMID: 23113351

The MicroRNA-29 Plays a Central Role in Osteosarcoma Pathogenesis and Progression

Overview
Journal Mol Biol (Mosk)
Publisher Izdatelstvo Nauka
Date 2012 Nov 2
PMID 23113351
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Osteosarcoma is the most common type of bone cancer, with a peak incidence in the early childhood. The relationship between microRNAs (miRNAs) and cancer development attracted more and more attention over the last few years. Members of the miRNA-29 family, including miRNA-29a, miRNA-29b, and miRNA-29c were shown to participate in the development of rhabdomyosarcoma and hepatocarcinogenesis. Here, it has been demonstrated miRNA-29a and miRNA-29b expression levels to be downregulated in most of the osteosarcoma tissues (23 from 30). Besides, miRNA-29a displayed ability to induce apoptosis in both U2OS and SAOS-2 osteoblastic cells. While miRNA-29 members induced apoptosis through p53 gene activation, the effect of miRNA-29a on osteoblastic cells was independent on p53 expression level. Moreover, Bcl-2 and Mcl-1 were earlier demonstrated to be the direct targets of miRNA-29 in many types of cancer tissues and cancers. In both U2OS and SAOS-2 osteoblastic cell types, overexpression of miRNA-29a also downregulated Bcl-2 and Mcl-1, while silencing of miRNA-29a increased their expression. In addition, enhanced expression of miRNA-29a increased the expression of two tumor suppressor genes, E2F1 and E2F3. In summary, data obtained highlight the role of miRNA-29a in the regulation of osteoblastic cell apoptosis by silencing Bcl-2 and Mcl-1 and inducing E2F1 and E2F3 expression.

Citing Articles

miRNAs: Potential as Biomarkers and Therapeutic Targets for Cancer.

Chakrabortty A, Patton D, Smith B, Agarwal P Genes (Basel). 2023; 14(7).

PMID: 37510280 PMC: 10378777. DOI: 10.3390/genes14071375.


miRNA: A Promising Therapeutic Target in Cancer.

Menon A, Abd-Aziz N, Khalid K, Poh C, Naidu R Int J Mol Sci. 2022; 23(19).

PMID: 36232799 PMC: 9569513. DOI: 10.3390/ijms231911502.


Integrated DNA Copy Number and Expression Profiling Identifies IGF1R as a Prognostic Biomarker in Pediatric Osteosarcoma.

Taylor A, Sun J, Yu A, Voicu H, Shen J, Barkauskas D Int J Mol Sci. 2022; 23(14).

PMID: 35887382 PMC: 9319262. DOI: 10.3390/ijms23148036.


COL3A1 and Its Related Molecules as Potential Biomarkers in the Development of Human Ewing's Sarcoma.

Tang M, Liu P, Wu X, Gong J, Weng J, Gao G Biomed Res Int. 2022; 2021:7453500.

PMID: 35047627 PMC: 8763479. DOI: 10.1155/2021/7453500.


MicroRNAs signatures, bioinformatics analysis of miRNAs, miRNA mimics and antagonists, and miRNA therapeutics in osteosarcoma.

Otoukesh B, Abbasi M, Gorgani H, Farahini H, Moghtadaei M, Boddouhi B Cancer Cell Int. 2020; 20:254.

PMID: 32565738 PMC: 7302353. DOI: 10.1186/s12935-020-01342-4.